CNTB · Categories · Form 4

CNTB - SEC Form 4 insider transactions

Connect Biopharma Holdings Limited (CNTB) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CNTB

• 56d
  Director Xanthopoulos Kleanthis Gabriel was granted 3,738 units of Ordinary Shares, increasing direct ownership by 5% to 86,554 units (SEC Form 4)

  4 - Connect Biopharma Holdings Ltd (0001835268) (Issuer)
• 56d
  Director Liu Jean I was granted 6,718 units of Ordinary Shares, increasing direct ownership by 133% to 11,779 units (SEC Form 4)

  4 - Connect Biopharma Holdings Ltd (0001835268) (Issuer)
• 146d
  SEC Form 4 filed by Xanthopoulos Kleanthis Gabriel

  4 - Connect Biopharma Holdings Ltd (0001835268) (Issuer)
• 146d
  SEC Form 4 filed by Liu Jean I

  4 - Connect Biopharma Holdings Ltd (0001835268) (Issuer)
• 147d
  SEC Form 4 filed by Huang James

  4 - Connect Biopharma Holdings Ltd (0001835268) (Issuer)

Other CNTB categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends